ATE210659T1 - Indolalkylderivate von benzodioxanmenthylamin als 5-ht1a rezeptor liganden - Google Patents

Indolalkylderivate von benzodioxanmenthylamin als 5-ht1a rezeptor liganden

Info

Publication number
ATE210659T1
ATE210659T1 AT96937782T AT96937782T ATE210659T1 AT E210659 T1 ATE210659 T1 AT E210659T1 AT 96937782 T AT96937782 T AT 96937782T AT 96937782 T AT96937782 T AT 96937782T AT E210659 T1 ATE210659 T1 AT E210659T1
Authority
AT
Austria
Prior art keywords
benzodioxanementhylamin
receptor ligands
alkyl derivatives
ht1a receptor
indole alkyl
Prior art date
Application number
AT96937782T
Other languages
English (en)
Inventor
Young Hee Kang
Gary Paul Stack
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Application granted granted Critical
Publication of ATE210659T1 publication Critical patent/ATE210659T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT96937782T 1995-11-06 1996-10-29 Indolalkylderivate von benzodioxanmenthylamin als 5-ht1a rezeptor liganden ATE210659T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US728495P 1995-11-06 1995-11-06
PCT/US1996/017275 WO1997017343A1 (en) 1995-11-06 1996-10-29 Indolealkyl derivatives of benzodioxanmethylamine as 5-ht1a receptor ligands

Publications (1)

Publication Number Publication Date
ATE210659T1 true ATE210659T1 (de) 2001-12-15

Family

ID=21725271

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96937782T ATE210659T1 (de) 1995-11-06 1996-10-29 Indolalkylderivate von benzodioxanmenthylamin als 5-ht1a rezeptor liganden

Country Status (20)

Country Link
US (1) US5750724A (de)
EP (1) EP0861248B1 (de)
JP (1) JP2000500136A (de)
KR (1) KR19990067303A (de)
CN (1) CN1074414C (de)
AR (1) AR004229A1 (de)
AT (1) ATE210659T1 (de)
BR (1) BR9611406A (de)
CA (1) CA2236678A1 (de)
DE (1) DE69617995T2 (de)
DK (1) DK0861248T3 (de)
ES (1) ES2166470T3 (de)
HU (1) HUP9902091A3 (de)
IL (1) IL124095A (de)
MX (1) MX9803455A (de)
NZ (1) NZ321821A (de)
PT (1) PT861248E (de)
TW (1) TW498075B (de)
WO (1) WO1997017343A1 (de)
ZA (1) ZA969221B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6231833B1 (en) 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
US6121307A (en) 1998-04-08 2000-09-19 American Home Products Corp. N-aryloxyethyl-indoly-alkylamines for the treatment of depression
JP2002544223A (ja) * 1999-05-12 2002-12-24 ソルベイ・フアーマシユーチカルズ・ベー・ブイ 精神病性障害の治療方法
ATE299142T1 (de) 1999-08-23 2005-07-15 Solvay Pharm Bv Phenylpiperazin-derivate als inhibitoren der serotonin-wiederaufnahme
FR2799463B1 (fr) * 1999-10-12 2004-04-16 Adir Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent
AR032712A1 (es) * 2001-02-21 2003-11-19 Solvay Pharm Bv Un mesilato de derivados de fenilpiperazina y composiciones farmaceuticas que lo contienen
US6656951B2 (en) 2001-04-24 2003-12-02 Wyeth 8-aza-bicyclo[3.2.1]octan-3-ol derivatives of 2,3-dihydro-1,4-benzodioxan as 5-HT1A antagonists
EP1381600A1 (de) 2001-04-24 2004-01-21 Wyeth, A Corporation of the State of Delaware Azaheterocyclylmethyldeivate von 2,3-dihydro-1,4-benzodioxan als antidepressiva
US7041683B2 (en) * 2001-04-24 2006-05-09 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1, 4-benzodiozan
US6656950B2 (en) * 2001-04-25 2003-12-02 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine
US8106074B2 (en) 2001-07-13 2012-01-31 Pierre Fabre Medicament Pyridin-2-yl-methylamine derivatives for treating opiate dependence
WO2003031439A1 (en) 2001-10-05 2003-04-17 Wyeth Antidepressant chroman and chromene derivatives of 3-(1,2,3,6-tetrahydro-4-pyridinyl)-1h-indole
US6911445B2 (en) 2002-09-12 2005-06-28 Wyeth Antidepressant cycloalkylamine derivatives of heterocycle-fused benzodioxans
US6800637B2 (en) * 2002-09-12 2004-10-05 Wyeth Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
US7227023B2 (en) 2003-04-30 2007-06-05 Wyeth Quinoline 3-amino chroman derivatives
AU2006214233A1 (en) * 2005-02-17 2006-08-24 Wyeth Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
KR20100135325A (ko) 2008-04-29 2010-12-24 엔에스아베 필리알 아프 뉴로서치 스웨덴 아베 스베리게 도파민 신경전달의 조절제
AU2009242095A1 (en) 2008-04-29 2009-11-05 Nsab, Filial Af Neurosearch Sweden Ab, Sverige Modulators of dopamine neurotransmission
EP2271635A1 (de) * 2008-04-29 2011-01-12 NSAB, Filial af NeuroSearch Sweden AB, Sverige Modulatoren der dopamin-neurotransmission
CN103965186B (zh) * 2013-01-25 2016-05-18 江苏恩华药业股份有限公司 苯并二噁烷-苯并噁（噻）唑哌啶衍生物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054104A (de) * 1962-07-20
JPS58219114A (ja) * 1982-06-15 1983-12-20 Mitsubishi Chem Ind Ltd 血圧降下剤
DE3419935A1 (de) * 1984-05-28 1985-11-28 Merck Patent Gmbh, 6100 Darmstadt Verwendung von hydroxyindolderivaten bei der senkung des blutdrucks
US4910302A (en) * 1988-12-19 1990-03-20 American Home Products Corporation Psychotropic polycyclic imides
CA2043709C (en) * 1990-06-29 2002-01-22 David W. Smith Antimigraine alkoxypyrimidine derivatives
DE4101686A1 (de) * 1991-01-22 1992-07-23 Merck Patent Gmbh Indolderivate
FR2707294B1 (fr) * 1993-07-06 1995-09-29 Pf Medicament Nouveaux dérivés de la 3,5-dioxo-(2H,4H)-1,2,4-triazine, leur préparation et leur application en thérapeutique humaine.
DE19512639A1 (de) * 1995-04-05 1996-10-10 Merck Patent Gmbh Benzonitrile und -fluoride

Also Published As

Publication number Publication date
AU704216B2 (en) 1999-04-15
EP0861248A1 (de) 1998-09-02
DE69617995T2 (de) 2002-05-16
BR9611406A (pt) 1999-01-05
HUP9902091A2 (hu) 2000-02-28
JP2000500136A (ja) 2000-01-11
IL124095A (en) 2001-10-31
WO1997017343A1 (en) 1997-05-15
ES2166470T3 (es) 2002-04-16
EP0861248B1 (de) 2001-12-12
HUP9902091A3 (en) 2000-03-28
AU7524596A (en) 1997-05-29
TW498075B (en) 2002-08-11
CN1074414C (zh) 2001-11-07
NZ321821A (en) 1999-07-29
KR19990067303A (ko) 1999-08-16
MX9803455A (es) 1998-09-30
DK0861248T3 (da) 2002-04-08
US5750724A (en) 1998-05-12
ZA969221B (en) 1998-05-04
PT861248E (pt) 2002-05-31
HK1015366A1 (en) 1999-10-15
CN1205700A (zh) 1999-01-20
DE69617995D1 (de) 2002-01-24
CA2236678A1 (en) 1997-05-15
AR004229A1 (es) 1998-11-04

Similar Documents

Publication Publication Date Title
ATE210659T1 (de) Indolalkylderivate von benzodioxanmenthylamin als 5-ht1a rezeptor liganden
DE69605430D1 (de) Chinolin-2-on derivate als serotonin antagonisten
ATE180785T1 (de) Kondensierte indol-derivate als 5-ht4-rezeptor- antagonisten
ATE197300T1 (de) Indolderivate als 5-ht rezeptorantagoniste
DE69628334D1 (de) Chinolin derivate als nk3 antagoniste
DE69612852D1 (de) BENZO[g]CHINOLINDERIVATE
ATE232850T1 (de) Tetrahydroisoquinoline derivate als modulatoren von dopamine d3 rezeptoren
DE69401823D1 (de) Indolin derivate als 5ht2c antagonisten
DK0820451T3 (da) Hidtil ukendte heterocykliske forbindelser
DE69603269D1 (de) Derivate von inulin
DE69801878D1 (de) Verwendung von Oxamatderivaten als Depigmentierungsmittel
MA24632A1 (fr) Derives de 2-(4-aryl-ou heteroaryl-piperazine-1-ylmethyle)-1h- indole
DE69626416D1 (de) Salze von chinolinderivaten als nk3 antagonisten
ATE222492T1 (de) Verwendung von indolderivaten als 5ht1-agonisten
NO20001387L (no) FremgangsmÕte for syntese av kinolinderivater
DK0975594T3 (da) Fremgangsmåde til fremstilling af indolderivater
DE69527785D1 (de) Chinuclidin-n-oxidderivate als muscarin rezeptor liganden
DK0725061T3 (da) Substituerede indolderivater
DE69617010D1 (de) Isazole derivate als fibrinogen-rezeptor-antagonisten
DE69705032D1 (de) Heterocyclyl-ergolinderivate als 5-ht1a rezeptor liganden
ATE210117T1 (de) Indolderivate als melatoninanaloge
DK0594475T3 (da) Hængselled til vindue af italiensk type
FI955933A7 (fi) Abeo-ergoliinijohdannaiset 5HT1A-ligandeina
ATE223380T1 (de) Heteroaryloxyethylaminen als 5-ht1a rezeptor liganden
IS1908B (is) Pýrrólidínýl metýl indól salt

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0861248

Country of ref document: EP

REN Ceased due to non-payment of the annual fee